Results 11 to 20 of about 3,331 (189)

Simultaneous determination of ethinyl estradiol and drospirenone in oral contraceptive by high performance liquid chromatography [PDF]

open access: yesBrazilian Journal of Pharmaceutical Sciences, 2013
A simple, rapid, economical and reliable high performance liquid chromatographic method has been developed and successfully applied in simultaneous determination of ethinyl estradiol and drospirenone in coated tablets.
Viviane Benevenuti Silva   +7 more
doaj   +2 more sources

Preparation and Evaluation of Intravaginal Ring Containing Drospirenone [PDF]

open access: yesAdvances in Pharmacological Sciences, 2013
In the present study, we investigated the feasibility of the vaginal administration of drospirenone silicone IVR. The in vitro release characteristics of matrix-type and reservoir-type IVR were compared under sink conditions in 21 days. At the same time,
Ying Zhang   +4 more
doaj   +2 more sources

EE-drospirenone-levomefolate calcium versus EE-drospirenone + folic acid: folate status during 24 weeks of treatment and over 20 weeks following treatment cessation

open access: yesInternational Journal of Women's Health, 2013
Konstanze Diefenbach,1 Dietmar Trummer,1 Frank Ebert,1 Michael Lissy,2 Manuela Koch,2 Beate Rohde,1 Hartmut Blode3 1Bayer HealthCare Pharmaceuticals, Berlin, Germany; 2Nuvisan GmbH, Neu-Ulm, Germany; 3Bayer HealthCare Pharmaceuticals Global R&D ...
Diefenbach K   +6 more
doaj   +1 more source

Drospirenone-containing oral contraceptives and venous thromboembolism: an analysis of the FAERS database

open access: yesOpen Access Journal of Contraception, 2018
David Madigan, Jennifer Shin Department of Statistics, Columbia University, New York, NY, USA Introduction: Substantial evidence suggests that drospirenone-containing oral contraceptives may cause a higher risk of venous thrombotic events than earlier ...
Madigan D, Shin J
doaj   +2 more sources

Safety, efficacy and patient acceptability of drospirenone and estradiol in the treatment of menopausal vasomotor symptoms: a review

open access: yesClinical Interventions in Aging, 2008
Sebastián Carranza-LiraReproductive Medicine, UMAE Hospital de Ginecología y Obstetricia “Luis Castelazo Ayala” Instituto Mexicano del Seguro Social, MéxicoAbstract: During menopause vasomotor symptoms are one of the main
Sebastián Carranza-Lira
doaj   +1 more source

Bioequivalence study of low dose drospirenone/ethinyl estradiol 3 mg/0.03 mg film tablets under fasting conditions in Turkish healthy female subjects

open access: yesPharmacology Research & Perspectives
This bioequivalence research aims to evaluate the relative bioavailability and pharmacokinetic characteristics of ethinyl estradiol and drospirenone in the test preparation in comparison to the reference preparation during fasting conditions.
Ahmet Inal   +7 more
doaj   +2 more sources

Drospirenone–Ethinyl Estradiol and Cyproterone Acetate in Moderate Severe Acne with Hyperandrogenism: A Randomized Double-Blind Trial [PDF]

open access: yesIndonesian Journal of Obstetrics and Gynecology
Background: Acne vulgaris is a health problem experienced by 85% of people in Indonesia. The highest prevalence is in women, who attempt to treat acne vulgaris. Unsuccessful acne vulgaris therapy is associated with hormonal influences, the stimulation of
Eka Rusdianto Gunardi   +3 more
doaj   +2 more sources

Efficacy of Drospirenone-Containing Hormone Replacement Therapy to Reduce Vasomotor Symptoms of Menopause

open access: yesPharmacy, 2013
Hormone replacement therapy has been proven efficacious for controlling vasomotor symptoms such as hot flushes associated with menopause. Drospirenone is a progestin with antiandrogenic and antimineralocorticoid activity that may be used in combination ...
Dana A. Brown   +2 more
doaj   +2 more sources

Low thrombin generation in users of a contraceptive containing estetrol and drospirenone [PDF]

open access: yes, 2022
OBJECTIVE: To compare the impact on thrombin generation of the new combined oral contraceptive containing 15 mg estetrol and 3 mg drospirenone with ethinylestradiol (30 or 20 mcg) associated either with 150 mcg levonorgestrel or with 3 mg drospirenone ...
Jost, Maud   +7 more
core   +1 more source

The estetrol-drospirenone-containing contraceptive as a drug of choice for patients with mastalgia

open access: yes, 2023
The problem of mastalgia is widespread: up to 70% of women report regular or episodic pain in the mammary gland. The role of benign breast disease in the occurrence of these complaints was noted only in 10–30% of cases, while in most women mastalgia is a
Mekan R. Orazov, Vasilii V. Ermakov
core   +1 more source

Home - About - Disclaimer - Privacy